Smith & Nephew plc
corporate_fare Company Profile
Smith & Nephew plc (NYSE:SNN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 28 items for SNN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Smith+Nephew's REGENETEN Implant Halves Rotator Cuff Recovery Times in New Clinical Trial
- Smith & Nephew Grants $58.8M in Performance and Deferred Share Awards to 12 Executives
- Activist Investor Cevian Capital Further Increases Stake in Smith & Nephew to Over 10%
- Activist Investor Cevian Capital Increases Stake to 9.6% with Over $80M in Recent Purchases
- Smith & Nephew Reports Strong 2025 Results, Launches New 'RISE' Growth Strategy, and Completes Share Buyback
Financial Snapshot
Insider Transactions
SNN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.